Windtree Therapeutics, Inc., a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, reported financial results for the second quarter ended June 30, 2020 and provided key business updates.
August 13, 2020
· 11 min read